本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corcept醫療

39.48
-1.3500-3.31%
成交量:31.62萬
成交額:1,263.75萬
市值:41.53億
市盈率:45.20
高:40.85
開:40.85
低:39.47
收:40.83
52周最高:117.33
52周最低:32.99
股本:1.05億
流通股本:8,687.53萬
量比:0.47
換手率:0.36%
股息:- -
股息率:- -
每股收益(TTM):0.8735
每股收益(LYR):1.23
淨資產收益率:16.70%
總資產收益率:5.10%
市淨率:6.57
市盈率(LYR):32.10

資料載入中...

公司資料

公司名字:
Corcept醫療
交易所:
NASDAQ
成立時間:
1998
員工人數:
500
公司地址:
101 Redwood Shores Parkway,Redwood City,California,United States
郵編:
94065
電話:
傳真:
- -
簡介:
Corcept Therapeutics Incorporated於1998年5月13日在特拉華州註冊成立。該公司是一家商業階段公司,從事發現和開發藥物,通過調節激素皮質醇的作用來治療嚴重的內分泌、腫瘤、代謝和神經系統疾病。

董事

名稱
職位
James N. Wilson
Chairman of the Board
Joseph K. Belanoff
Director,Chief Executive Officer and President
Daniel N. Swisher, Jr.
Director
David L. Mahoney
Director
G. Leonard Baker, Jr.
Director
Gregg Alton
Director
Joshua M. Murray
Director
Kimberly Park
Director

股東

名稱
職位
Joseph K. Belanoff
Director,Chief Executive Officer and President
Atabak Mokari
Chief Financial Officer and Treasurer
Charles Robb
Chief Business Officer and Secretary
Hazel Hunt
Chief Scientific Officer
Joseph D. Lyon
Chief Accounting and Technology Officer
Sean Maduck
President, Corcept Endocrinology
William Guyer
Chief Development Officer